Prognostication biomarkers in CAP

Welcome viewers!

Anastomos has collaborated with the esteemed Dr. Pradeep Rangappa,  a Senior Consultant at the Intensive Care Unit (ICU), and brings to you some highly informative and authentic content. Stay tuned to learn a lot today!

Today's topic: Prognostication biomarkers in CAP.

Prognostication biomarkers in Community-Acquired Pneumonia (CAP) are indicators used to predict the outcome of the disease. These biomarkers help assess the severity of pneumonia, guide treatment decisions, and anticipate the risk of complications, aiding in patient management and prognosis.

Best wishes,

Team Anastomos.